Research Radboud technology centers Radboud Biobank News COREON and the Dutch Code of Conduct on data protection in health research
25 February 2020

Peggy Manders has been appointed to the COREON management committee (Committee on Regulation of Health Research). COREON endeavors to foster careful and responsible research with health data and human materials (i.e. biospecimens and/or images), while striking a fair balance between public interests, participant protection and involvement, and scientific interests.
 
COREON is currently revising the Dutch Code of Conduct for data protection in health research. This work is financially supported by ZonMw. In mid-2020, the Code of Conduct draft will be submitted for a public round. The Code of Conduct is expected to be completed and published in the first quarter of 2021. Up-to-date information about the new Code of Conduct is available via the website (available in Dutch only).
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


New Automated PBMC isolation method introduced in LMI.

21 September 2021

The Radboud Biobank (RB) and the laboratory of Medical Immunology (LMI) are making plans to replace the density gradient centrifugation method with a new automated PBMC isolation method, the AutoMACS Pro Separator.

read more

Health-RI, geared up to accelerate

21 September 2021

The Dutch cabinet has selected Health-RI's National Growth Fund proposal for a national health data infrastructure. On 5 October, the kick-off will take place during a live meeting in Jaarbeurs Media Plaza in Utrecht.

read more

SUNRISE-CRC sub-biobank

21 September 2021

The main purpose of SUNRISE-CRC is to determine whether treatment with a high dose of sunitinib provides a better chance of survival and slows the progression of (colo)rectal cancer (CRC) more than standard treatment with TAS-102.

read more

PRECISE sub-biobank

21 September 2021

The aim of the PRECISE biobank is to develop the first, smart multi-modal liquid biopsy test service for the prediction of immune checkpoint inhibitor response in urothelial cancer (UC) patients – the PRECISE IVD.

read more

Lysine Metabolism sub-biobank

21 September 2021

Hereditary metabolic disorders form a large group of more than 1,400 rare disorders in which an error in the DNA causes abnormalities in the process in which proteins, fats and carbohydrates are converted into smaller building materials and energy.

read more

Hyperintense sub-biobank

21 September 2021

Cerebral small vessel disease (SVD), encompasses a collection of pathologies that affect the smallest blood vessels in the brain.

read more